Form D/A
View Original Filing
Notice of Exempt Offering of Securities
Item 1. Issuer's Identity
Name of Issuer:
OVASCIENCE, INC.
Jurisdiction of Incorporation/Organization
DE
Year of Incorporation/Organization
2011
Item 2 Issuer Principal Place of Business and Contact Information
215 FIRST STREET
SUITE 240
CAMBRIDGE, MA 02142
Phone Number:
subscription required
Item 3. Related Persons
Name
MICHELLE DIPP
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
CHRISTOPHER A. BLECK
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
SCOTT CHAPPEL
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
RICHARD ALDRICH
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
JEFF CAPELLO
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
STEPHEN KRAUS
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
JONATHAN TILLY
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
CHRISTOPH WESTPHAL
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
JOHN SIMON
Address
subscription required
Relationship(s)
Clarification of Response
Item 4. Industry Group
BIOTECHNOLOGY
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE
Item 6. Federal Exemptions and Exclusions Claimed
Item 7. Type of Filing
Amendment
Date of First Sale in this Offering:
06/21/2012
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
No
Item 9. Type(s) of Securities Offered
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
0
Item 12. Sales Compensation
Recipient
LEERINK SWANN LLC
Recipient CRD Number
39011
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
1 FEDERAL STREET
37TH FLOOR
BOSTON, MA 02110
States of Solicitation
Item 12. Sales Compensation
Recipient
LIVINGSTON SECURITIES, LLC
Recipient CRD Number
147364
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
825 THIRD AVENUE
SUITE 223
NEW YORK, NY 10022
States of Solicitation
- RI
- DE
- MS
- NC
- NY
- CA
- WY
- NH
- PA
- OH
- AR
- CT
- MD
- MI
- NJ
- KY
- AZ
- TN
- OR
- NM
- MA
Item 13. Offering and Sales Amounts
Total Offering Amount
3635946
Total Amount Sold
3635946
Total Remaining to be Sold
0
Clarification of Response
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
80
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
218157.0
Finders' Fees
0.0
Clarification of Response
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response
Signature and Submission
Issuer Name
OVASCIENCE, INC.
Issuer Signature
/S/ MICHELLE DIPP
Signer Name
MICHELLE DIPP
Signer Title
PRESIDENT AND CHIEF EXECUTIVE OFFICER
Signature Date
07/20/2012